Quarterly report pursuant to Section 13 or 15(d)

STOCK OPTIONS (Details Narrative)

v3.22.2.2
STOCK OPTIONS (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]          
Stock option intrinsic value $ 19   $ 19   $ 107
Stock option granted     2,741,555    
Stock option weighted average exercise price     $ 1.06    
Option, exercised     332,730    
Proceeds from option exercise     $ 377 $ 569  
Common Stock [Member]          
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]          
Option, exercised   176,735 332,730 509,465  
Shares issued, shares     332,730    
Proceeds from option exercise     $ 377    
Employees and Consultants [Member]          
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]          
Stock option granted     2,741,555    
Stock option weighted average exercise price     $ 1.06    
Stock option grant date fair value     $ 2,622    
Stock option plan expense 387   1,292    
Unrecognized share-based compensation expense $ 2,793   $ 2,793